Virtual, online and hybrid medical meetings are here to stay.
Expect to see a virtual component even when in-person medical meetings resume.

If you didn’t fall in love with virtual medical meetings in 2020, let’s just say you’re not alone. They came with their fair share of downsides, including the smaller volume of presented data and the lack of face-to-face conversations about how to translate findings into clinical practice.

But while it’s safe to say the industry is eager to get back to live conferences, there are some aspects of the virtual experience you can expect to see follow us into 2021 and beyond—even after in-person meetings resume.

What started out as a mad dash to adapt to a new format eventually became an opportunity for both medical organizations and pharma companies to raise the bar when it came to disseminating study results. As doctors got more comfortable accessing presentations online, drugmakers refined the way they delivered information—and many of them were pleased with the outcome.

The truth is that virtual medical meetings changed how companies share clinical data in a way that is very likely to be the norm, moving forward.

One potential result? A hybrid conference model featuring both in-person and virtual attendance options.

While we cannot do everything remotely, we have learned quite a bit in this last year about what’s feasible to be done and what is already on the horizon, leveraging the virtual components that are effective.

It’s not difficult to see the appeal of such a model from where pharma’s standing. Virtual audiences only give drugmakers a bigger stage from which to trumpet their newest positive results.

One of the real benefits of virtual medical meetings is the reach and number of participants from around the globe that have been able to benefit from seeing the presentation of scientific data in real-time and been able to be exposed to some really important data sets.

Ease of access is another great feature of the virtual setting, it is possible to have access to the data just by clicking on different rooms or sections of the event, without having to walk from one side of the convention center to the other.

More importantly, virtual access allows practitioners to attend conferences without having to be away from their patients.

But while virtual conferences have their advantages, make no mistake, execs predicted: As soon as organizations can safely convene in-person medical meetings, they’re going to do it.

Nobody wants to give up on in-person meetings, that still is an essential venue for people to interact and stakeholders will want to have the experience as soon as that can be done again safely. The societies are going to be keen to try to get back to in-person meetings.

The difference now is: the old mantra of online as a poor option for medical meetings is over. Virtual, online and hybrid models can be equally - or even more - successful and engaging in communicating important scientific information to the healthcare community.


Based on this article.



AI’s Transformational Impact on the Patient-Physician Relationship.

The Transformational Impact of Artificial Intelligence on the Relationship Between Physicians and Patients.In today’s ever-evolving healthcare landscape, the integration of…

What is Medical Communications? The definitive guide.

Medical Communications. The demand for clear and integrated dissemination of scientific knowledge is critical for the Pharmaceutical industry. Medical communications—or…

Enhancing engagement with healthcare professionals (HCPs): How AI is transforming Pharma relationships.

Pharmaceutical companies are progressively turning to the use of Artificial Intelligence (AI) as a tool to transform several aspects of…

Six communication trends Pharma needs to watch in 2024.

Six Communication trends Pharma needs to watch in 2024.As we approach 2024, the Pharma industry’s focus on developing and maintaining…

The EU Artificial Intelligence Act: A New Era of Regulation 
The EU's proposed AI Act, the world's first comprehensive legal framework for AI, is set to revolutionize global AI regulation. Learn about its risk classification levels and the potential implications for the Life Sciences industry.
0 +



0 +




0 +



Whether you’re looking for effective solutions to transition F2F meetings to a virtual or online environment, support with clinical trials, medical advisory boards, symposia, key opinion leader (KOL) management, internal medical training, medical writing or speaker training programs and more, count on our 16-year experience and expertise over 40 therapeutic areas.

SDM also offers strategic consulting services and can help with communication and engagement of your target audiences as part of market development opportunities.

Discover why over 95% of clients are “Extremely Satisfied” with SDM and over 90% say the agency deliver “Much more than expected”.